Clinical Trial Update: FOLFOXIRI Plus Panitumumab Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only [Phase 2]

View source ↗

Summary

Phase 2 trial assessing FOLFOXIRI plus panitumumab in metastatic KRAS wild-type colorectal cancer with liver metastases; results were completed and posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• FOLFOXIRI regimen (FOLFOXIRI)
• Panitumumab (panitumumab)

Snippet

Sponsor: SCRI Development Innovations, LLC | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2015-05-27